IND-SWIFT LABORATORIES LTD. - 532305 - Announcement under Regulation 30 (LODR)-Joint Venture
Intimation of Investment in a Joint Venture23-06-2022
23-06-2022
IND-SWIFT LABORATORIES LTD. - 532305 - Disclosure Under Regulation 23(9) Of The SEB! (LODR) Regulations, 2015 And SEBI Circular SEBI/HO/CFD/CMD1/ CIR/P/2021/662-Resubmission
Disclosure under Regulation 23(9) of the SEB! (LODR) Regulations, 2015 And SEBI Circular SEBI/HO/CFD/CMD1/ CIR/P/2021/662-Resubmission16-06-2022
IND-SWIFT LABORATORIES LTD. - 532305 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015- Update on Arbitration proceedings with PI Industries Limited.01-06-2022
IND-SWIFT LABORATORIES LTD. - 532305 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Annual Secretarial Compliance Report for the year ended 31st March, 2022 pursuant to Regulation 24A of SEBI (LODR) Regulations, 2015.30-05-2022
IND-SWIFT LABORATORIES LTD. - 532305 - Audited Financial Results For The Quarter And Financial Year Ended 31.03.2022
Audited Financial Results for the Quarter and Financial Year ended 31.03.202228-05-2022
IND-SWIFT LABORATORIES LTD. - 532305 - Board Meeting Outcome for OUTCOME OF BOARD MEETING
OUTCOME OF BOARD MEETING28-05-2022
IND-SWIFT LABORATORIES LTD. - 532305 - Board Meeting Intimation for Considering The Standalone And Consolidated Audited Financial Results Of The Company. For The Fourth Quarter (Q4) And Financial Year Ended March 31, 2022.
IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company. for the Fourth Quarter (Q4) and Financial Year ended March 31, 2022.16-05-2022
IND-SWIFT LABORATORIES LTD. - 532305 - Compliance Certificate Under Regulation 40 (9) & 40 (10)
Compliance Certificate under Regulation 40 (9) & 40 (10)30-04-2022
IND-SWIFT LABORATORIES LTD. - 532305 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayIND-SWIFT LABORATORIES LTD. 2CINL24232CH1995PLC015553 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 869.74 4Highest Credit Rating during the previous FY -BB 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CARE RATINGS LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PARDEEP VERMA Designation: AVP CORPORATE AFFAIRS COMPANY sSCRETARY EmailId: [email protected] Name of the Chief Financial Officer: Gagan Aggarwal Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.29-04-2022